Stack Financial Management Inc Lowers Holdings in Becton, Dickinson and Company (BDX)

Stack Financial Management Inc lessened its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 0.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 76,756 shares of the medical instruments supplier’s stock after selling 392 shares during the period. Stack Financial Management Inc’s holdings in Becton, Dickinson and were worth $15,040,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in BDX. Almanack Investment Partners LLC. bought a new position in shares of Becton, Dickinson and in the 1st quarter valued at about $105,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in shares of Becton, Dickinson and by 55.8% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock valued at $131,000 after acquiring an additional 240 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Becton, Dickinson and by 8.1% in the 2nd quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock valued at $133,000 after acquiring an additional 51 shares in the last quarter. Harfst & Associates Inc. grew its holdings in shares of Becton, Dickinson and by 46.4% in the 2nd quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock valued at $135,000 after acquiring an additional 221 shares in the last quarter. Finally, Financial Architects Inc grew its holdings in shares of Becton, Dickinson and by 8.0% in the 2nd quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock valued at $142,000 after acquiring an additional 54 shares in the last quarter. Hedge funds and other institutional investors own 86.71% of the company’s stock.

Becton, Dickinson and Company (NYSE BDX) opened at $224.41 on Monday. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $224.89. The company has a current ratio of 5.56, a quick ratio of 5.01 and a debt-to-equity ratio of 1.48. The company has a market capitalization of $51,067.86, a PE ratio of 23.65, a P/E/G ratio of 1.78 and a beta of 1.04.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.37 by $0.03. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.14 billion. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period last year, the business posted $2.12 earnings per share. analysts forecast that Becton, Dickinson and Company will post 10.6 EPS for the current fiscal year.

In other Becton, Dickinson and news, insider Thomas E. Polen, Jr. sold 5,971 shares of the firm’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the completion of the sale, the insider now directly owns 12,861 shares in the company, valued at $2,538,890.01. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Linda M. Tharby sold 4,695 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $200.48, for a total transaction of $941,253.60. Following the sale, the executive vice president now owns 18,670 shares of the company’s stock, valued at $3,742,961.60. The disclosure for this sale can be found here. Insiders have sold 75,904 shares of company stock valued at $15,242,688 over the last 90 days. Company insiders own 1.40% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.com-unik.info/2017/11/06/stack-financial-management-inc-lowers-holdings-in-becton-dickinson-and-company-bdx.html.

Several brokerages have recently weighed in on BDX. Barclays PLC restated an “equal weight” rating and issued a $210.00 price objective (up previously from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. BidaskClub cut Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 price objective for the company in a report on Tuesday, October 31st. Piper Jaffray Companies restated a “buy” rating and issued a $213.00 price objective on shares of Becton, Dickinson and in a report on Tuesday, September 12th. Finally, Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Five investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $213.47.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

What are top analysts saying about Becton Dickinson and Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Becton Dickinson and Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit